logo BDSP

Base documentaire


  1. Shared care for benign prostatic hyperplasia : a feasibility study.

    Article - En anglais

    Objective To determine the proportion of patients with symptoms of urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) who could be managed in the community after assessment in a shared-care clinic (managed by nursing staff, supervised by a consultant) to which they had direct access.

    Patients and methods A total of 127 men were referred to one consultant urologist in a 9-month period for assessment of possible urinary outflow obstruction.

    All were investigated using urine analysis, serum prostate-specific antigen level, urea and electrolytes, plain abdominal X-ray, renal ultrasonography and urinary flow rate.

    Additional investigations were undertaken as required.

    The proportion of men who could have been investigated in a shared-care clinic and then managed in the community was determined.

    Results Of 127 men, 88 (69%) were found to have uncomplicated outflow obstruction secondary to BPH ; of these 49 (38%) could have been managed in the community after assessment in the shared-care clinic and a further 27 (21%) could have been managed in the community after additional investigation by a specialist.

    Twelve men (9%) were found to have uncomplicated outflow obstruction and chose to undergo transurethral resection of the prostate.

    Conclusion Many men with uncomplicated outflow obstruction could be assessed in a shared-care clinic and then managed in the community.

    A shared-care protocol for the management of these men has now been introduced in this unit.

    Mots-clés Pascal : Adénome, Prostate, Homme, Obstruction, Voie urinaire, Traitement, Ambulatoire, Faisabilité, Royaume Uni, Europe, Appareil urinaire pathologie, Appareil génital mâle pathologie, Prostate pathologie, Tumeur bénigne, Voie urinaire pathologie

    Mots-clés Pascal anglais : Adenoma, Prostate, Human, Obstruction, Urinary tract, Treatment, Ambulatory, Feasibility, United Kingdom, Europe, Urinary system disease, Male genital diseases, Prostate disease, Benign neoplasm, Urinary tract disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0429531

    Code Inist : 002B14D02. Création : 01/03/1996.